Tt Nominees Limited For And On Behalf Of Oxford Technology And Innovations Eis Fund investment portfolio

Biofidelity Ltd develops and supplies blood‑based genomic biomarker tests for early cancer detection and monitoring, delivering precision genomic testing services to healthcare providers, laboratories, patients and biopharma companies.

Lightcast Discovery Ltd develops a micro‑fluidic platform (Envisia) that enables high‑throughput, single‑cell functional analysis of cell heterogeneity, interactions and biomolecule secretion. Its technology is marketed to pharmaceutical and biotechnology companies for applications such as drug discovery, antibody development, cell‑therapy research and other cell‑based research programmes.